Prevalence and prognosis of asymptomatic coronary artery disease in patients with abdominal aortic aneurysm and minor or no perioperative risks

Circulation Journal

Volumn 73, Issue 7, 2009, Pages 1203-1209

  Takigawa, Masateru ^a,b   Yokoyama, Naoyuki ^a   Yoshimuta, Tsuyoshi ^a   Takeshita, Satoshi ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Abdominal aortic aneurysm; AHA ACC guideline; Asymptomatic coronary artery disease; Risk

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; AGING; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL EVALUATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DIET THERAPY; FAMILY HISTORY; FEMALE; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERIOPERATIVE COMPLICATION; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCINTIGRAPHY; SILENT MYOCARDIAL ISCHEMIA; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL; SYMPTOM; TELEPHONE;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 68149171461     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-08-1135     Document Type: Article

References (36)

1. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF 3rd, Graor RA, et al. Coronary artery disease in peripheral vascular patients: A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223-233.
2. Lachapelle K, Graham AM, Symes JF. Does the clinical evaluation of the cardiac status predict outcome in patients with abdominal aortic aneurysms? J Vasc Surg 1992; 15: 964-970; discussion 970-971.
3. Kioka Y, Tanabe A, Kotani Y, Yamada N, Nakahama M, Ueda T, et al. Review of coronary artery disease in patients with infrarenal abdominal aortic aneurysm. Circ J 2002; 66: 1110-1112.
4. Sukhija R, Aronow WS, Yalamanchili K, Sinha N, Babu S. Prevalence of coronary artery disease, lower extremity peripheral arterial disease, and cerebrovascular disease in 110 men with an abdominal aortic aneurysm. Am J Cardiol 2004; 94: 1358-1359. (Pubitemid 39469972)
5. Hollier LH, Plate G, O'Brien PC, Kazmier FJ, Gloviczki P, Pairolero PC, et al. Late survival after abdominal aortic aneurysm repair: Influence of coronary artery disease. J Vasc Surg 1984; 1: 290-299. (Pubitemid 15061410)
6. Roger VL, Ballard DJ, Hallett JW Jr, Osmundson PJ, Puetz PA, Gersh BJ. Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: A population-based study, 1971-1987. JAm Coll Cardiol 1989; 14: 1245-1252.
7. Johnston KW. Nonruptured abdominal aortic aneurysm: Six-year follow-up results from the multicenter prospective Canadian aneurysm study [Canadian Society for Vascular Surgery Aneurysm Study Group]. J Vasc Surg 1994; 20: 163-170.
8. Koskas F, Kieffer E. Long-term survival after elective repair of infra-renal abdominal aortic aneurysm: Results of a prospective multicentric study: Association for Academic Research in Vascular Surgery (AURC). Ann Vasc Surg 1997; 11: 473-481.
9. Hertzer NR, Mascha EJ, Karafa MT, O'Hara PJ, Krajewski LP, Beven EG. Open infrarenal abdominal aortic aneurysm repair: The Cleveland Clinic experience from 1989 to 1998. J Vasc Surg 2002; 35: 1145-1154.
10. Eagle KA, Berger PB, Calkins H, Chairman BR, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002; 39: 542-553 (erratum in: J Am Coll Cardiol 2006; 47: 2356).
11. Japanese Society of Nephrology. Special issue: Clinical practice guidebook for diagnosis and treatment of CKD. Nippon Jinzo Gakkai Shi 2007; 49: 757-861 (in Japanese).
12. Hertzer NR, Young JR, Kramer JR, Phillips DF, deWolfe VG, Ruschhaupt WF 3rd, et al. Routine coronary angiography prior to elective aortic reconstruction: Results of selective myocardial revascularization in patients with peripheral vascular disease. Arch Surg 1979; 114: 1336-1344.
13. Utah J, Goto H, Hirata T, Hara M, Kitamura N. Routine coronary angiography prior to abdominal aortic aneurysm repair: Incidence of silent coronary artery disease. Panminerva Med 1998; 40: 107-109. (Pubitemid 128528879)
14. Back MR, Leo F, Cuthbertson D, Johnson BL, Shamesmd ML, Bandyk DF. Long-term survival after vascular surgery: Specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg 2004; 40: 752-760. (Pubitemid 39311644)
15. Feringa HH, Karagiannis S, Vidakovic R, Noordzij PG, Brugts JJ, Schouten O, et al. Comparison of the incidences of cardiac arrhythmias, myocardial ischemia, and cardiac events in patients treated with endovascular versus open surgical repair of abdominal aortic aneurysms. Am J Cardiol 2007; 100: 1479-1484. (Pubitemid 47576033)
16. Back MR, Leo F, Cuthbertson D, Johnson BL, Shamesmd ML, Bandyk DF. Long-term survival after vascular surgery: Specific influence of cardiac factors and implications for preoperative evaluation. J Vasc Surg 2004; 40: 752-760. (Pubitemid 39311644)
17. Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris: The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 1992; 340: 1421-1425.
18. Stone PH, Gibson RS, Glasser SP, DeWood MA, Parker JD, Kawanishi DT, et al. Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina: Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms: The ASIS Study Group. Circulation 1990; 82: 1962-1972.
19. Snow V, Barry P, Fihn SD, Gibbons RJ, Owens DK, Williams SV, et al. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: A clinical practice guideline from the American College of Physicians. Ann Intern Med 2004; 141: 562-567 (erratum in: Ann Intern Med 2005; 142: 79).
20. Deedwania PC, Carbajal EV, Nelson JR, Hait H. Anti-ischemic effects of atenolol versus nifedipine in patients with coronary artery disease and ambulatory silent ischemia. J Am Coll Cardiol 1991; 17: 963-969.
21. Pepine CJ, Cohn PF, Deedwania PC, Gibson RS, Handberg E, Hill JA, et al. Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life: The Atenolol Silent Ischemia Study (ASIST). Circulation 1994; 90: 762-768. (Pubitemid 24242742)
22. Knatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, et al. Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol 1994; 24: 11-20 (erratum in: JAm Coll Cardiol 1995; 26: 842). (Pubitemid 24202770)
23. Deedwania PC, Pool PE, Thadani U, Eff J. Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris: Dilacor XR Ambulatory Ischemia Study Group. Am J Cardiol 1997; 80: 421-425.
24. Von Arnim T. Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis: Results of the Total Ischemic Burden Bisoprolol Study (TIBBs) follow-up. J Am Coll Cardiol 1996; 28: 20-24. (Pubitemid 26266618)
25. Kawanishi DT, Reid CL, Morrison EC, Rahimtoola SH. Response of angina and ischemia to long-term treatment in patients with chronic stable angina: A double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination. J Am Coll Cardiol 1992; 19: 409-417.
26. Kohro T, Hayashi D, Okada Y, Yamazaki T, Nagai R. Effects of medication on cardiovascular events in the Japanese coronary artery disease (JCAD) study. Circ J 2007; 71: 1835-1840.
27. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
28. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-1009.
29. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
30. Itakura H, Kita T, Mabuchi H, Matsuzaki M, Matsuzawa Y, Nakaya N, et al. Relationship between coronary events and serum cholesterol during 10 years of low-dose simvastatin therapy: Long-term efficacy and safety in Japanese patients with hypercholesterolemia in the Japan Lipid Intervention Trial (J-LIT) Extension 10 Study, a prospective large-scale observational cohort study. Circ J 2008; 72: 1218-1224.
31. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al, JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
32. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med 1988; 319: 332-337. (Pubitemid 18190886)
33. Passamani E, Davis KB, Gillespie MJ, Killip T. A randomized trial of coronary artery bypass surgery: Survival of patients with a low ejection fraction. N Engl J Med 1985; 312: 1665-1671. (Pubitemid 15068573)
34. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 2005; 352: 2174-2183. (Pubitemid 40727084)
35. Erne P, Schoenenberger AW, Zuber M, Burckhardt D, Kiowski W, Dubach P, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: The SWISSI II randomized controlled trial. JAMA 2007; 297: 1985-1991. (Pubitemid 46740350)
36. Hayden M, Pignone M, Phillips C, Mulrow C. Aspirin for the primary prevention of cardiovascular events: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 136: 161-172.